Ocular Therapeutix, Inc. (OCUL)
11.12
-0.30
(-2.67%)
USD |
NASDAQ |
Jan 22, 16:00
11.21
+0.10
(+0.85%)
After-Hours: 20:00
Ocular Therapeutix EPS Diluted (Quarterly): -0.3774 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.5048 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Dynavax Technologies Corp. | 0.2063 |
| Vertex Pharmaceuticals, Inc. | 4.204 |
| Krystal Biotech, Inc. | 2.660 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -69.42M |
| Revenue (Quarterly) | 14.54M |
| Total Expenses (Quarterly) | 83.96M |
| Enterprise Value | 2.165B |
| Gross Profit Margin (Quarterly) | 87.80% |
| Profit Margin (Quarterly) | -477.3% |
| Earnings Yield | -12.92% |
| Normalized Earnings Yield | -12.84 |